Bayer is increasingly shifting the commercial focus of its pharmaceutical business away from Europe and toward the US and China, Stefan Oelrich, head of the German group...

Stolthaven Terminals and partner Revivegen Environmental Technology have opened their joint venture terminal in Taiwan. The facility, operated by Stolthaven Revivegen...

Germany inaugurated its second liquefied natural gas (LNG) import terminal on Jan. 14 in the Baltic seacoast town of Lubmin, in the presence of chancellor Olaf Scholz and...

US biopharma manufacturing and technology company National Resilience has entered into an agreement with Abu Dhabi investor Mubadala Investment Company to build a...

The aim of Tokyo, Japan-headquartered Tsubame BHB is to commercialize on-site ammonia production at small-scale plants using an electride-based catalyst. The Company now...

As it continues to leverage earnings from its top-selling mRNA-based Covid vaccine to deepen its existing knowhow, Mainz, Germany-based BioNtech has announced plans to...

US specialty chemicals and materials company Chemours will spend $200 million to increase capacity for its Nafion ion exchange membranes at its site in Villers-Saint-Paul...

Venator’s second-largest investor, Czech private equity fund J&T MS 1 SICAV, is asking for a seat on the board of the UK-headquartered multinational pigments and...